[Data Insights] Multiple institutions actively accumulate shares of Haixi Innovation, while three prominent speculative funds collaborate with quantitative investors to make large purchases of "Ma-character" stocks.

①Haitai Innovation surged 20% today with four institutions purchasing RMB 224 million worth of shares. ②Stocks bearing the character 'Ma' remained notably active against the market trend today, with Wanli Ma's stock surging 20%, driven by significant purchases from three top-tier speculative funds and a quantitative trading seat.

cls.cnNov 4 17:47

High-value innovative drugs gain a new payment channel: The 2025 National Reimbursement Drug List negotiation to establish a commercial insurance catalog for the first time.

This year's catalog adjustment will, for the first time, establish a commercial insurance innovation drug directory, providing a new access pathway for high-value innovative drugs.

Zhitong FinanceNov 2 10:10

The ChiNext Index fell by more than 1%, with notable declines in key optoelectronic module companies such as New Easyconn and Tianfu Communication. The Hang Seng Tech Index fluctuated to a 0.2% gain, while government bonds declined and commodities rose.

In the morning session, CRO concept stocks experienced a broad decline, with Wuxi Apptec falling more than 7%. Other significant decliners included Opthea, Sunshine Nohe, and Rui Zhi Medicine. PCB (Printed Circuit Board) concept stocks also saw adjustments, with Jingwang Electronics dropping over 7%, while Zhongfu Circuit and Fangbang Co., Ltd. fell more than 5%. Shenghong Technology declined by 5%. The industrial mother machine concept performed actively, with Huadong Numerical Control hitting the price limit, and Yuhuan Numerical Control having previously hit the price limit.

wallstreetcnOct 30 10:05

Insights from the 11th National Drug Procurement Bidding: Price Negotiations Across 55 Products Reflect Optimized Procurement Rules Reshaping Industry Dynamics

① The bidding of the eleventh batch of national procurement by enterprises was more rational compared to previous rounds, with a steadier mindset among businesses; ② The bargaining advantage of major brands became evident while expectations for lesser-known companies declined; ③ A total of 272 enterprises were granted tentative winning qualifications, with patients expected to access this batch of nationally procured products by February next year.

cls.cnOct 29 12:31

Passenger Vehicle Benchmark Posts Impressive Q3 Results: Net Profit Surges 79% YoY | After-Hours Earnings Highlights

The third-quarter report of a 70 billion yuan bus manufacturing leader has been released. A global leading enterprise in the PCB industry plans to go public in Hong Kong. A stock in the decoration and building materials sector, which has seen three consecutive limit-ups, issued an unusual trading activity announcement...

Golden10 DataOct 28 21:03

Express News | Hong Kong-listed innovative drug concept stocks collectively rose, with Wuxi Apptec surging over 7% post-earnings, Wuxi XDC gaining nearly 7%, Wuxi Bio and Ascletis Pharma rising nearly 6%, and Hengrui Pharma and XtalPi Holdings up nearly 4%.

BreakingsOct 27 09:35